The tumor suppressor p53 is inactivated by genetic mutations in many cancers, except for neuroblastoma. New findings show that this cancer reversibly inhibits p53 through a microRNA, miR-380-5p (pages 1134–1140). Blocking it to restore p53 function may be an attractive therapeutic option for neuroblastomas.
- Angelika Eggert
- Johannes H Schulte